We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+0.05%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.55B
AUM Growth
+$59.4M
Cap. Flow
+$77M
Cap. Flow %
2.17%
Top 10 Hldgs %
49.57%
Holding
665
New
156
Increased
155
Reduced
111
Closed
128

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$138M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$131M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$127M
4
MRO
Marathon Oil Corporation
MRO
+$123M
5
CHX
ChampionX
CHX
+$98.3M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$638M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$51.2M
3
DFS
Discover Financial Services
DFS
+$45.1M
4
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$18.4M
5
NSC icon
Norfolk Southern
NSC
+$17.7M

Sector Composition

Rank Sector Weight
1 Energy 26.53%
2 Technology 21.03%
3 Healthcare 14.68%
4 Industrials 8.19%
5 Materials 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
276
KALA BIO
KALA
$14.2M
$1.05M 0.03%
2,951
+1,500
+103% +$496K
MFA
277
MFA Financial
MFA
$915M
$1.04M 0.03%
97,421
-12,379
-11% -$133K
ON icon
278
ON Semiconductor
ON
$18.6B
$1.03M 0.03%
15,000
-12,500
-45% -$877K
KROS icon
279
Keros Therapeutics
KROS
$211M
$1.03M 0.03%
22,453
+5,400
+32% +$290K
ATXS
280
DELISTED
Astria Therapeutics
ATXS
$1.03M 0.03%
112,665
+4,545
+4% +$44.4K
OFIX icon
281
Orthofix Medical
OFIX
$432M
$1.02M 0.03%
76,998
-7,251
-9% -$99.4K
PTCT icon
282
PTC Therapeutics
PTCT
$5.91B
$1.01M 0.03%
33,000
+18,000
+120% +$583K
XRX icon
283
PUT
Xerox
XRX
$424M
$998K 0.03%
278,300
-16,500
-6% -$240K
AXGN icon
284
Axogen
AXGN
$2.38B
$996K 0.03%
137,575
– –
RCUS icon
285
Arcus Biosciences
RCUS
$3.61B
$993K 0.03%
65,187
+1,065
+2% +$17.2K
PEN icon
286
Penumbra
PEN
$12.8B
$989K 0.03%
5,498
-300
-5% -$59.9K
SMAR
287
DELISTED
Smartsheet Inc.
SMAR
$988K 0.03%
+22,416
New +$894K
PTON icon
288
PUT
Peloton Interactive
PTON
$2.38B
$978K 0.03%
500,000
-225,000
-31% -$806K
DECK icon
289
Deckers Outdoor
DECK
$13.3B
$968K 0.03%
+6,000
New +$923K
ARCO icon
290
Arcos Dorados Holdings
ARCO
$1.76B
$963K 0.03%
+107,023
New +$1.1M
KPTI icon
291
Karyopharm Therapeutics
KPTI
$44.2M
$957K 0.03%
73,493
+25,338
+53% +$420K
VRT icon
292
Vertiv
VRT
$106B
$952K 0.03%
11,000
-54,300
-83% -$4.94M
INSM icon
293
Insmed
INSM
$28.9B
$949K 0.03%
14,169
-39,338
-74% -$1.53M
ABT icon
294
Abbott
ABT
$187B
$935K 0.03%
+9,000
New +$954K
BBIO icon
295
BridgeBio Pharma
BBIO
$16.2B
$925K 0.03%
+36,500
New +$998K
INZY
296
DELISTED
Inozyme Pharma
INZY
$915K 0.03%
205,218
+22,000
+12% +$107K
BTG icon
297
B2Gold
BTG
$5.45B
$904K 0.03%
+334,874
New +$904K
TRIS
298
DELISTED
Tristar Acquisition I Corp.
TRIS
$899K 0.03%
80,656
– –
CPT icon
299
Camden Property Trust
CPT
$11B
$898K 0.03%
8,227
+3,852
+88% +$398K
PTON icon
300
Peloton Interactive
PTON
$2.38B
$879K 0.02%
+260,000
New +$931K
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2024 Portfolio in Review

As of Q2 2024, UBS O'Connor held 665 positions worth $3.55B, up 1.7% from $3.49B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

UBS O'Connor's Q2 2024 filing shows 156 new, 155 increased, 111 reduced and 128 closed positions. Its largest new stake was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M. The largest sale was Pioneer Natural Resource Co., an estimated $638M.

By sector, the portfolio is most concentrated in Energy at 27% of assets, down from 34% a quarter earlier, followed by Technology and Healthcare.

  • UBS O'Connor's largest Q2 2024 buy was Endeavor Group Holdings, Inc.: 4,789,930 shares worth $129M.
  • UBS O'Connor added most to HashiCorp, Inc. Class A Common Stock in Q2 2024, an estimated $138M increase.
  • UBS O'Connor's biggest Q2 2024 reduction was Cerevel Therapeutics Holdings, Inc. Common Stock, cutting an estimated $51.2M.
  • UBS O'Connor fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $638M.
  • UBS O'Connor's ten largest holdings make up 50% of its $3.55B portfolio in Q2 2024.
  • UBS O'Connor opened 156 new positions and closed 128 in Q2 2024.
  • UBS O'Connor's portfolio value rose 1.7% quarter-over-quarter to $3.55B.

Based on UBS O'Connor's 13F filing for Q2 2024, filed 14 Aug 2024.